SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,619,224 | -52.5% | 112,331 | -50.0% | 0.85% | -51.2% |
| Q1 2023 | $45,487,518 | +215.4% | 224,663 | +100.2% | 1.73% | +217.8% |
| Q4 2022 | $14,420,621 | +97.4% | 112,214 | +110.2% | 0.54% | +82.3% |
| Q3 2022 | $7,305,000 | -78.8% | 53,387 | -72.6% | 0.30% | -78.0% |
| Q2 2022 | $34,536,000 | -27.5% | 195,183 | -41.0% | 1.36% | -18.8% |
| Q1 2022 | $47,617,000 | -22.9% | 330,561 | -17.3% | 1.67% | -15.9% |
| Q4 2021 | $61,767,000 | +75.4% | 399,527 | +92.7% | 1.99% | +75.2% |
| Q3 2021 | $35,205,000 | +5.8% | 207,334 | -1.6% | 1.13% | +4.9% |
| Q2 2021 | $33,275,000 | +6.3% | 210,759 | -6.5% | 1.08% | +0.4% |
| Q1 2021 | $31,312,000 | -39.1% | 225,490 | -23.2% | 1.08% | -40.4% |
| Q4 2020 | $51,424,000 | – | 293,619 | – | 1.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |